Tocilizumab can be useful to treat giant cell arteritis combined with prednisone

Authors

  • Asier Mitxelena Osakidetza

Keywords:

autoimmunity, arteritis, giant cell arteritis, tocilizumab, monoclonal antibody

Abstract

Tocilizumab combined with prednisone was superior to prednisone and placebo with regard to sustained glucocorticoid-free remission: 56% with weekly tocilizumab and prednisone (26 weeks); 53% with biweekly tocilizumab and prednisone (26 weeks); 18% with prednisone and placebo (52 weeks) and %14 with prednisone and placebo (26 weeks).

Author Biography

Asier Mitxelena, Osakidetza

Barne-Medikuntzako medikua Donostia Ospitale Unibertsitarioan

Downloads

Published

2021-07-01

How to Cite

Mitxelena, A. (2021). Tocilizumab can be useful to treat giant cell arteritis combined with prednisone. Osagaiz: Osasun-Zientzien Aldizkaria, 5(1). Retrieved from https://aldizkariak.ueu.eus/index.php/osagaiz/article/view/356

Issue

Vol. 5 No. 1 (2021)

Section

Kritikoki Aztertutako Testuak